Answers are grounded in this paper and cite their sources.
Background and Objectives Differentiating cerebral amyloid angiopathy (CAA) from Alzheimer disease (AD) is essential for prognosis and clinical management. However, pathophysiology-based molecular biomarkers are lacking. Tau deposition may offer discriminative signals: It occurs late in primary cortices including pericentral cortex in AD but may emerge earlier and more diffusely in CAA. We investigated whether a pericentral-predominant pattern of tau deposition distinguishes CAA from AD and characterize its cortical spatial distribution and contributing factors in CAA. Methods We consecutively enrolled healthy controls and patients with CAA and AD with amyloid (18F-florbetapir) and tau (18F-florzolotau) PET. We compared pericentral tau-PET retention (both standardized uptake value ratios [SUVRs] and regional-to-global ratios) between CAA, AD, and controls and identified optimal cutoffs differentiating CAA from AD. We validated the discriminative performance using 18F-flortaucipir tau-PET in an external cohort. We assessed correlates of tau deposition in multivariable regression analyses and analyzed hierarchical patterns of tau involvement using conditional probability analyses in CAA. Results The derivation cohort included 22 controls, 80 CAA, and 64 AD (mean age 60.1, 68.4, and 66.3 years; 50.0%, 38.8%, and 50.0% female). The validation cohort included 65 CAA and 19 AD (mean age 74.1 and 73.6 years; 53.8% and 68.4% female). Patients with CAA showed higher global and pericentral tau SUVRs compared with controls but lower than AD. However, pericentral-to-global tau ratios were significantly higher in CAA than AD (0.93 ± 0.07 vs 0.82 ± 0.08, p < 0.001). A cutoff of 0.90 yielded 68.9% (95% CI 58.6–79.6) sensitivity and 87.1% (95% CI 79.1–96.1) specificity in the derivation cohort (AUC = 0.836, 95% CI 0.768–0.904) and 63.1% (95% CI 54.8–71.7) and 94.7% (95% CI 89.5–100), respectively, in the validation cohort (AUC = 0.844, 95% CI 0.747–0.940) for differentiating CAA from AD. In CAA, pericentral tau deposition correlated with regional amyloid deposition (coefficient 0.680, 95% CI 0.489–0.870, p < 0.001) and white matter hyperintensities volume (coefficient 0.001, 95% CI 0.00003–0.001, p = 0.040) and followed parieto-occipital cortices but preceded medial cortex involvement. Discussion Higher pericentral-to-global tau ratio differentiates CAA from AD and may reflect spatial distribution patterns potentially influenced by both amyloid and vascular pathology.
No takes yet. Share an insight, caveat, or question.
Su et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: